Novan to Host Analyst and Investor Event: A Discussion of Molluscum’s Unmet Need with Pediatric Dermatologist Jeffrey Sugarman, MD, PhD
20 avr. 2023 09h00 HE
|
Novan, Inc.
DURHAM, N.C., April 20, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will host an Analyst and Investor Event: A Discussion of Molluscum’s...
Catalyst Pharmaceuticals Announces Third-Party Abstracts on FYCOMPA® (Perampanel) to be Presented at the Upcoming American Academy of Neurology 2023 Annual Meeting
20 avr. 2023 08h03 HE
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., April 20, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on...
NeOnc Technologies Appoints Sidra Medicine CEO and Forbes Top 100 Healthcare Leader, Dr. Iyabo Tinubu-Karch, to Scientific Advisory Board
18 avr. 2023 09h15 HE
|
NeOnc Technologies Holdings, Inc.
LOS ANGELES, April 18, 2023 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc., a clinical stage medical biotechnology company, has appointed Dr. Iyabo Tinubu-Karch to its scientific advisory...
Pediatric Vaccines Market to Surpass US$ 69,482.2 Million by 2030, Says Coherent Market Insights (CMI)
04 avr. 2023 09h15 HE
|
CMI
Burlingame, April 04, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, Global pediatric vaccines market is estimated to be valued at US$ 46,424.3 million in 2023 and is expected to...
AB2 Bio Completes Enrolment in Pivotal Phase 3 Trial of Tadekinig alfa to Treat Primary Monogenic IL-18 Driven HLH
07 mars 2023 03h00 HE
|
AB2 Bio Ltd
Topline pivotal Phase 3 results expected during second half of 2023Potential new treatment option in ultra-rare, life-threatening, primarily pediatric disease with no approved therapies Lausanne...
NeOnc Technologies Engages Anova Enterprises to Pursue Pediatric Brain Tumor Indication and FDA Fast-Track Status for NEO100®
06 mars 2023 08h00 HE
|
NeOnc Technologies Holdings, Inc.
Anova Enterprises, a clinical research organization, to prepare FDA Fast Track and Rare Pediatric Designation application for NEO100® for Pediatric High-Grade Gliomas (pHGGS) brain tumors.AnovaOS™...
Canadians Agree: It’s Time for All Levels of Government to Prioritize Children’s Health
06 févr. 2023 17h32 HE
|
Children’s Healthcare Canada
OTTAWA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Nearly all Canadians agree that it is time for decision-makers to put children first in health care planning and spending. New public opinion research,...
NeuroSigma Announces Strategic Digital Marketing Partnership with Data360
31 janv. 2023 09h00 HE
|
NeuroSigma, Inc.
LOS ANGELES, Jan. 31, 2023 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company commercializing external trigeminal nerve stimulation (eTNS) technology for treating...
WishBone Medical Partners With Clubfoot Solutions to Distribute the Iowa Brace for Pediatric Patients in the U.S.
05 janv. 2023 08h00 HE
|
WishBone Medical, Inc.
WARSAW, Ind., Jan. 05, 2023 (GLOBE NEWSWIRE) -- WishBone Medical, Inc. has entered into a distribution agreement with Clubfoot Solutions, naming WishBone the exclusive pediatric medical device...
San Antonio TX Dentist Dr. Carlen Blume of Blume Pediatric Dentistry Interviewed by Qamar Zaman
19 déc. 2022 21h28 HE
|
The Subject Matter Expert Podcast by Qamar Zaman
San Antonio, TX, Dec. 19, 2022 (GLOBE NEWSWIRE) -- In 2010, Dr. Carlen Blume established her pediatric dentistry practice and has become one of the go-to full-service pediatric care providers...